Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patientsJihye Kim, Seung Woon Paik, Wonseok Kang et al.|Clinical and Molecular Hepatology|2020Cited by 88
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT StudyAndrea Casadei‐Gardini, Stefano Cascinu, Margherita Rimini et al.|Liver Cancer|2022Cited by 43
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung‐Suk Lim, Seungbong Han, Ming‐Lung Yu et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 23
The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related VirusesEui‐Cheol Shin, Sung Key Jang, Ji Won Han et al.|Viruses|2020Cited by 7